133 related articles for article (PubMed ID: 10228847)
1. Locoregional chemotherapy in pancreatic cancer.
Nazli O; Tansug T; Bozdag AD; Cln N; Kaymak E
Hepatogastroenterology; 1999; 46(25):479-82. PubMed ID: 10228847
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
3. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
5. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.
Hayashibe A; Kameyama M; Shinbo M; Makimoto S
Ann Surg Oncol; 2007 Jan; 14(1):190-4. PubMed ID: 17066232
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
7. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
8. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
[TBL] [Abstract][Full Text] [Related]
9. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
[TBL] [Abstract][Full Text] [Related]
10. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
11. [Influence of adjuvant therapy on survival of patients with pancreatic carcinoma of body and tail: a report of 137 cases].
Xie YB; Wang CF; Li CR; Shan Y; Zhao DB; Tian YT; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):951-4. PubMed ID: 19671304
[TBL] [Abstract][Full Text] [Related]
12. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
13. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
Gebauer T; Ridwelski K; Fahlke J; Lippert H
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
[TBL] [Abstract][Full Text] [Related]
14. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
15. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
16. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
Lygidakis NJ; Papadopoulou P
Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid carcinoma: is there a role for adjuvant radiation therapy?
Munson ND; Foote RL; Northcutt RC; Tiegs RD; Fitzpatrick LA; Grant CS; van Heerden JA; Thompson GB; Lloyd RV
Cancer; 2003 Dec; 98(11):2378-84. PubMed ID: 14635072
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
20. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
